Skip to content

Clinical trials

Phase 2 Muscular Dystrophies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Phase: Phase 2 Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fulcrum Therapeutics2
Avidity Biosciences, Inc.1
PepGen Inc1
Santhera Pharmaceuticals1
Satellos Bioscience, Inc.1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies7
Neuromuscular Diseases5
Muscular Dystrophy, Duchenne3
Muscular Dystrophy, Facioscapulohumeral3
Musculoskeletal Diseases3
Genetic Diseases, Inborn1
Heredodegenerative Disorders, Nervous System1
Muscular Diseases1
Muscular Disorders, Atrophic1
Myotonia1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.